• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】65270

【品名】 

【CA登记号】 

【 分 子 式 】C20H29NO5

【 分 子 量 】363.454

【元素组成】C 66.09% H 8.04% N 3.85% O 22.01%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(VIIIb)

Condensation of (1S,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl tosylate (I) with 3(R)-benzyloxypyrrolidine (II) provides vernakalant benzyl ether (III), which is then debenzylated by catalytic hydrogenolysis over Pd/C (1). In a more direct approach, tosylate (I) is condensed with 3(R)-hydroxypyrrolidine (IV) to provide vernakalant (1, 2). An alternative strategy consists of the cyclization of (1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexylamine (V) with (R )-2-acetoxysuccinic anhydride (VI) by means of acetyl chloride or with ethyl 4-chloro-3(R )-hydroxybutyrate (VII) to give, respectively, the cyclic imide (VIIIa) or the pyrrolidinone (VIIIb), which is subsequently reduced and deprotected by means of Red-Al to yield the title hydroxypyrrolidine derivative (2). The O-benzyl precursor of vernakalant (III) can alternatively be obtained by condensation of 2(R )-[3(R )-benzyloxy-1-pyrrolidinyl]cyclohexan-1(R )-ol (IX) with 3,4-dimethoxyphenethyl trichloroacetimidate (X) (prepared from dimethoxyphenethyl alcohol [XI] and trichloroacetonitrile) in the presence of trifluoromethanesulfonic acid (2, 3). A related strategy for preparing the succinimide precursor of vernakalant (VIIIa) consists of the condensation of 2(R)-acetoxy-N-[2(R)-hydroxy-1(R)-cyclohexyl]succinimide (XII) with imidate (X) in the presence of boron trifluoride etherate (4). Scheme 1.

1 Beatch, G.N., Choi, L.S.L., Jung, G. et al. (Cardiome Pharma Corp.). Aminocyclohexyl ether compounds and uses thereof. EP 1560812, EP1666459, JP 2006525227, WO 2004099137.
2 Plouvier, B.M.C., Chou, D.T.H., Jung, G. et al. (Cardiome Pharma Corp.). Synthetic process for aminocyclohexyl ether compounds. WO 2006088525.
3 Machiya, K., Ike, K., Watanabe, M., Yoshino, T., Okamoto, T., Morinaga, Y., Mizobata, S. (Astellas Pharma, Inc.). Production method of optically active cyclohexane ether compounds. WO 2006075778.
4 Roth, C.J., Jung, G., Plouvier, B.M.C., Chou, D.T.H., Yee, J.G.K. (Cardiome Pharma Corp.). Synthetic processes for the preparation of aminocyclohexyl ether compounds. WO 2006138673.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIIIa) 65269     C22H29NO7 详情 详情
(VIIIb) 65270     C20H29NO5 详情 详情
(I) 65263 (1S,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl tosylate   C23H30O6S 详情 详情
(II) 65264 (3R)-benzyloxypyrrolidine   C11H15NO 详情 详情
(III) 65265 vernakalant benzyl ether   C27H37NO4 详情 详情
(IV) 14490 (3R)tetrahydro-1H-pyrrol-3-ol; R-3-hydroxypyrrolidine 2799-21-5 C4H9NO 详情 详情
(V) 65266 (1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexylamine   C16H25NO3 详情 详情
(VI) 65267 (2R)-acetoxysuccinic anhydride 79814-40-7 C6H6O5 详情 详情
(VII) 65268 ethyl 4-chloro-(3R)-hydroxybutyrate; 90866-33-4 C6H11ClO3 详情 详情
(IX) 65271 (2R)-[(3R)-benzyloxy-1-pyrrolidinyl]cyclohexan-(1R)-ol   C16H25NO2 详情 详情
(X) 65272 3,4-dimethoxyphenethyl trichloroacetimidate   C12H14Cl3NO3 详情 详情
(XI) 38711 2-(3,4-dimethoxyphenyl)-1-ethanol 7417-21-2 C10H14O3 详情 详情
(XII) 65273 (2R)-acetoxy-N-[(2R)-hydroxy-(1R)-cyclohexyl]succinimide   C12H17O5 详情 详情
Extended Information